Science
Research leads to ground-breaking treatments which improve the care and quality of life for people living with skin conditions.
Where Scientific Innovation, Discovery and Clinical Dermatology Converge
Michael Rosenblum, MD, PhD, was a 20-year-old undergraduate at the University of British Columbia when his mother became ill with breast cancer. At the time, physician-scientists were just beginning to explore how the immune system could be directed to target cancer cells. At the forefront was Dr. Steven Rosenberg, who had written a book that…
From Bedside to Bench and Back Again
The turning point in the career of John Harris, MD, PhD, was sudden and an appealing type of serendipity. He had just completed his PhD studying type 1 diabetes in the lab of Dr. Aldo Rossini at UMass Chan Medical School, where he had become fascinated with autoimmunity. But he had grown frustrated that they…
Dr. Aimee Payne’s Path to Creating CAAR-T Cell Therapies
In 2011, Aimee Payne, MD, PhD, was running a lab at the University of Pennsylvania, studying pemphigus vulgaris, an autoimmune disease of the skin that results when B cells make antibodies that attack the cell-adhesion protein desmoglein 3.
Serving the Underserved, Encouraging the Underrepresented
Hidradenitis suppurativa (HS) was a skin disease Dr. Ginette Okoye had never given much thought to before she entered her first faculty appointment.
In Hot Pursuit of Morphea
This article provides an overview of Dr. Heidi T. Jacobe’s wide range of contributions and associated insights. They provide critical guidance to practitioners now in diagnosing, assessing, and treating patients with morphea. And they will ultimately enable significant advances in treating this high-impact disease.